FOY: [Ethyl -(6-guanidinohexanoyloxy) benzoate] methanesulfonate as a serine proteinase inhibitor. II. effect on coagulo-fibrinolytic system in comparison with heparin or aprotinin
- 1 December 1981
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 24 (5-6) , 445-452
- https://doi.org/10.1016/0049-3848(81)90078-5
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- FOY: [Ethylp-(6-guanidinohexanoyloxy) benzoate] methanesulfonate as a serine proteinase inhibitor. I. Inhibition of thrombin and factor Xa in vitroThrombosis Research, 1980
- Inhibitory effects of gabexate mesilate (FOY) on experimental DICBlood & Vessel, 1979
- Effect of FOY in Intravascular Coagulation in RatsBlood & Vessel, 1979
- Activation of intrinsic or extrinsic blood coagulation in experimental venous thrombosis and disseminated intravascular coagulation: Pathogenetic differencesThrombosis Research, 1979
- Effect of Trasylol® on fibrin deposition and elimination in the lungs of rats with intravascular coagulation induced by thrombin or thromboplastinThrombosis Research, 1974
- The Purification and Mechanism of Action of Human Antithrombin-Heparin CofactorJournal of Biological Chemistry, 1973
- Inhibitory effects of ω-guanidino acid esters on trypsin, plasmin, plasma kallikrein and thrombinBiochimica et Biophysica Acta (BBA) - Enzymology, 1972
- Organ Distribution of Fibrin in Disseminated Intravascular CoagulationBritish Journal of Haematology, 1969
- Quantiative Determination of Intravascular Coagulation in the Lungs of Experimental AnimalsScandinavian Journal of Haematology, 1969